Literature DB >> 35915371

Transcriptomic Profile Identifies Hippocampal Sgk1 as the Key Mediator of Ovarian Estrogenic Regulation on Spatial Learning and Memory and Aβ Accumulation.

Mengying Liu1,2, Biyao Lian3,4, Zhen Lan2, Huan Sun2,5, Yangang Zhao6, Tao Sun2, Zhaoyou Meng2, Chengjun Zhao7,8, Jiqiang Zhang9.   

Abstract

Previous studies have shown that ovarian estrogens are involved in the occurrence and pathology of Alzheimer's disease (AD) through regulation on hippocampal synaptic plasticity and spatial memory; however, the underlying mechanisms have not yet been elucidated at the genomic scale. In this study, we established the postmenopausal estrogen-deficient model by ovariectomy (OVX). Then, we used high-throughput Affymetrix Clariom transcriptomics and found 143 differentially expressed genes in the hippocampus of OVX mice with the absolute fold change ≥ 1.5 and P < 0.05. GO analysis showed that the highest enrichment was seen in long-term memory. Combined with the response to steroid hormone enrichment and GeneMANIA network prediction, the serum and glucocorticoid-regulated kinase 1 gene (Sgk1) was found to be the most potent candidate for ovarian estrogenic regulation. Sgk1 overexpression viral vectors (oSgk1) were then constructed and injected into the hippocampus of OVX mice. Morris water maze test revealed that the impaired spatial learning and memory induced by OVX was rescued by Sgk1 overexpression. Additionally, the altered expression of synaptic proteins and actin remodeling proteins and changes in CA1 spine density and synapse density induced by OVX were also significantly reversed by oSgk1. Moreover, the OVX-induced increase in Aβ-producing BACE1 and Aβ and the decrease in insulin degrading enzyme were significantly reversed by oSgk1. The above results show that multiple pathways and genes are involved in ovarian estrogenic regulation of the function of the hippocampus, among which Sgk1 may be a novel potent target against estrogen-sensitive hippocampal dysfunctions, such as Aβ-initiated AD.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Bioinformatics; Hippocampus; Ovariectomy; Sgk1; Transcriptomics

Mesh:

Substances:

Year:  2022        PMID: 35915371     DOI: 10.1007/s11064-022-03690-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  59 in total

Review 1.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

2.  The Regulatory Functionality of Exosomes Derived from hUMSCs in 3D Culture for Alzheimer's Disease Therapy.

Authors:  Lingyan Yang; Yuanxin Zhai; Ying Hao; Zhanchi Zhu; Guosheng Cheng
Journal:  Small       Date:  2019-12-16       Impact factor: 13.281

3.  Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease.

Authors:  Akihiro Nakamura; Fanxing Zeng; Sayaka Nakamura; Kyle T Reid; Eric Gracey; Melissa Lim; Lin Leng; Sungsin Jo; Ye-Soo Park; Masaki Kusuda; Rohan Machhar; Shaghayegh F Boroojeni; Brian Wu; Evgeny Rossomacha; Tae-Hwan Kim; Francesco Ciccia; Jason S Rockel; Mohit Kapoor; Robert D Inman; Igor Jurisica; Sarah Q Crome; Richard Bucala; Nigil Haroon
Journal:  Sci Transl Med       Date:  2021-10-20       Impact factor: 17.956

Review 4.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

Review 5.  Targeting the β secretase BACE1 for Alzheimer's disease therapy.

Authors:  Riqiang Yan; Robert Vassar
Journal:  Lancet Neurol       Date:  2014-02-17       Impact factor: 44.182

Review 6.  Viewpoints: how the hippocampus contributes to memory, navigation and cognition.

Authors:  John Lisman; György Buzsáki; Howard Eichenbaum; Lynn Nadel; Charan Ranganath; A David Redish
Journal:  Nat Neurosci       Date:  2017-10-26       Impact factor: 24.884

Review 7.  A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.

Authors:  Francesco Panza; Bruno P Imbimbo; Madia Lozupone; Giancarlo Logroscino
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

8.  Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.

Authors:  Bikash R Sahoo; Pritam Kumar Panda; Wenguang Liang; Wei-Jen Tang; Rajeev Ahuja; Ayyalusamy Ramamoorthy
Journal:  J Mol Biol       Date:  2021-04-16       Impact factor: 6.151

9.  Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer's Disease.

Authors:  Roberta Marongiu
Journal:  Front Aging Neurosci       Date:  2019-09-06       Impact factor: 5.750

10.  Targeted Activation of Hippocampal Place Cells Drives Memory-Guided Spatial Behavior.

Authors:  Nick T M Robinson; Lucie A L Descamps; Lloyd E Russell; Moritz O Buchholz; Brendan A Bicknell; Georgy K Antonov; Joanna Y N Lau; Rebecca Nutbrown; Christoph Schmidt-Hieber; Michael Häusser
Journal:  Cell       Date:  2020-11-06       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.